Central de notícias >
Histórias de destaque
A Janssen nas manchetes
Comunicados à imprensa
Dec 21, 2019
United States
Complete Response Letter Issued from U.S. FDA for Investigational Long-Acting HIV Regimen
Dec 20, 2019
United States
Johnson & Johnson Acquires TARIS Biomedical with Focus on Transforming the Treatment of Bladder Cancer
Dec 19, 2019
Belgium
SPRAVATO®▼ (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder
Dec 10, 2019
United States
DARZALEX® (Daratumumab) Regimen Shows Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Dec 09, 2019
United States
DARZALEX® (Daratumumab) Shows Overall Survival Benefit and Continued Improvement in Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant
Dec 08, 2019
United States
Johnson & Johnson Announces Commitment to Support Republic of Rwanda's Preparedness Against Ebola Outbreak
Tweets
Janssen Global
@JanssenGlobal
-
Sebastián is a graphic designer and a painter in Buenos Aires, Argentina. His #multiplemyeloma diagnosis and relap… https://t.co/7TSSBs6VYP
2 days 15 hours ago

Fechar
Galeria de arte
Temos orgulho em apresentar obras de arte criadas por pessoas afetadas pelas doenças com as quais estamos comprometidos em tratar e prevenir.
Ver a galeria

